標(biāo)題: Titlebook: Genome Editing in Biomedical Sciences; Geraldo A. Passos Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive licens [打印本頁(yè)] 作者: 轉(zhuǎn)變 時(shí)間: 2025-3-21 16:53
書(shū)目名稱(chēng)Genome Editing in Biomedical Sciences影響因子(影響力)
書(shū)目名稱(chēng)Genome Editing in Biomedical Sciences影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Genome Editing in Biomedical Sciences網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Genome Editing in Biomedical Sciences網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Genome Editing in Biomedical Sciences被引頻次
書(shū)目名稱(chēng)Genome Editing in Biomedical Sciences被引頻次學(xué)科排名
書(shū)目名稱(chēng)Genome Editing in Biomedical Sciences年度引用
書(shū)目名稱(chēng)Genome Editing in Biomedical Sciences年度引用學(xué)科排名
書(shū)目名稱(chēng)Genome Editing in Biomedical Sciences讀者反饋
書(shū)目名稱(chēng)Genome Editing in Biomedical Sciences讀者反饋學(xué)科排名
作者: Oafishness 時(shí)間: 2025-3-21 21:11
https://doi.org/10.1007/978-3-531-90712-3We conclude that gene editing has been able to change quickly the scenario of these disorders, allowing the development of new therapies and improving the knowledge on disease pathogenesis. Should they confirm their hype, the first gene editing-based products for lysosomal disorders could be available in the next years.作者: 1分開(kāi) 時(shí)間: 2025-3-22 03:26
Genome Editing Tools for Lysosomal Storage Disorders,We conclude that gene editing has been able to change quickly the scenario of these disorders, allowing the development of new therapies and improving the knowledge on disease pathogenesis. Should they confirm their hype, the first gene editing-based products for lysosomal disorders could be available in the next years.作者: 結(jié)果 時(shí)間: 2025-3-22 07:00 作者: Ringworm 時(shí)間: 2025-3-22 08:52 作者: 點(diǎn)燃 時(shí)間: 2025-3-22 13:24
,Friendship in the Fathers’ Later Lives,icroRNAs and long noncoding RNAs. In this context, CRISPR/Cas9 emerges as a potential tool to modify gene sequence and modulate gene expression in thyroid cancer cell lines. In this chapter, we explore some of the current studies in which researchers have applied CRISPR/Cas9 in vitro to investigate thyroid cancer biology (Fig. .).作者: 點(diǎn)燃 時(shí)間: 2025-3-22 18:48
The CRISPR/Cas System in Human Cancer,llular and animal model generation, and new derivative tools applied to cancer research. CRISPR has opened new frontiers increasing the knowledge about cancer, pointing to new solutions to overcome several challenges to better understand the disease and design better treatments.作者: 脆弱么 時(shí)間: 2025-3-23 01:13
Using CRISPR/Cas9 to Edit a Thyroid Cancer Cell Line,icroRNAs and long noncoding RNAs. In this context, CRISPR/Cas9 emerges as a potential tool to modify gene sequence and modulate gene expression in thyroid cancer cell lines. In this chapter, we explore some of the current studies in which researchers have applied CRISPR/Cas9 in vitro to investigate thyroid cancer biology (Fig. .).作者: flimsy 時(shí)間: 2025-3-23 03:58
Joanne M. McKeown,Catherine G. FineNA targeting in tumorigenesis and drug resistance. Additionally, we highlighted the perspectives and potential applications of CRISPR approaches to treat cancer, as an emerging and promising target therapy.作者: 會(huì)犯錯(cuò)誤 時(shí)間: 2025-3-23 06:06 作者: 最小 時(shí)間: 2025-3-23 10:12
,Rektifikation in Füllk?rpers?ulen,ed to investigate the role of TFAM in mitochondrial mechanics and biogenesis as well as its correlation to mitochondrial disorders. Thus this chapter brings a summary of mitochondria function, dysfunction, the importance of . in the maintenance of mitochondria, and state of the art of gene editing tools involving TFAM and mtDNA.作者: 瑣事 時(shí)間: 2025-3-23 15:19
Long Non-coding RNAs and CRISPR-Cas Edition in Tumorigenesis,NA targeting in tumorigenesis and drug resistance. Additionally, we highlighted the perspectives and potential applications of CRISPR approaches to treat cancer, as an emerging and promising target therapy.作者: farewell 時(shí)間: 2025-3-23 21:39
Genome Editing for Engineering the Next Generation of Advanced Immune Cell Therapies,s between cancer cells and T cells further restrict the access to these therapies. Here, we described how cutting-edge genome editing approaches have been applied to unlock the full potential of these revolutionary therapies, thereby increasing therapeutic efficacy and patient accessibility.作者: Surgeon 時(shí)間: 2025-3-24 00:18 作者: commodity 時(shí)間: 2025-3-24 03:27 作者: Enervate 時(shí)間: 2025-3-24 08:00 作者: Jogging 時(shí)間: 2025-3-24 11:49 作者: BILIO 時(shí)間: 2025-3-24 16:20
Control of Bleeding in Uremic Patientssy way. In this chapter, we will briefly present the history behind the development of this innovative tool, how it emerged from a natural bacterial mechanism for antiviral defense, its key components (Cas9 endonuclease and single guide RNA), mode of action (DNA cleavage and repair via NHEJ or HDR),作者: Overdose 時(shí)間: 2025-3-24 20:20
https://doi.org/10.1007/978-981-15-0516-4rch disciplines, with some of the main beneficiaries being the fields of medicine and life sciences. Genetically engineered mouse models (GEMMs), along with other model organisms, are fundamentally important research tools frequently utilised to enhance our understanding of pathophysiology and biolo作者: 新陳代謝 時(shí)間: 2025-3-25 03:13
Joanne M. McKeown,Catherine G. Finet the transcriptional and post-transcriptional levels. Due to their role in cell growth and differentiation, lncRNAs have emerged as an important biomarker in cancer diagnosis, prognosis, and targeted treatment. Recent studies have focused on elucidating lncRNA function during malignant transformati作者: febrile 時(shí)間: 2025-3-25 07:21 作者: Somber 時(shí)間: 2025-3-25 08:50
,Friendship in the Fathers’ Later Lives,he oncogenesis of thyroid cancer is related to genetic alterations in MAPK signaling that induce proliferation and modulate noncoding genes, such as microRNAs and long noncoding RNAs. In this context, CRISPR/Cas9 emerges as a potential tool to modify gene sequence and modulate gene expression in thy作者: regale 時(shí)間: 2025-3-25 14:43 作者: Ibd810 時(shí)間: 2025-3-25 16:57
,The New Guard’s Musical Masculinity,0 deaths per year. Despite intense research efforts on Chagas disease and its causative agent, there is still a lack of effective treatments or strategies for disease control. Although significant progress has been made toward the elucidation of molecular mechanisms involved in host-parasite interac作者: 補(bǔ)助 時(shí)間: 2025-3-25 23:43 作者: ironic 時(shí)間: 2025-3-26 00:10 作者: Blazon 時(shí)間: 2025-3-26 04:30
,Rektifikation in Füllk?rpers?ulen, phosphorylation. Mitochondria have their own DNA, mitochondrial DNA (mtDNA), keeping the function of the mitochondria. Mitochondrial transcription factor A (TFAM) is a member of the HMGB subfamily that binds to mtDNA promoters is and considered essential in mtDNA replication and transcription. More作者: Misgiving 時(shí)間: 2025-3-26 12:32
,Rektifikation in Füllk?rpers?ulen, and social media. Across these spheres, there is a multilayered debate: scientific and technical aspects are discussed, as much as legal frameworks, ethics, responsibilities, politics, and social issues. But beyond these similarities, there are three notable differences. The first concerns (geo)pol作者: abnegate 時(shí)間: 2025-3-26 16:06 作者: sterilization 時(shí)間: 2025-3-26 18:17
The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: infringe 時(shí)間: 2025-3-26 20:56
Genome Editing in Biomedical Sciences978-3-031-33325-5Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: Breach 時(shí)間: 2025-3-27 04:46 作者: murmur 時(shí)間: 2025-3-27 08:36 作者: 水獺 時(shí)間: 2025-3-27 12:42 作者: 無(wú)孔 時(shí)間: 2025-3-27 15:20 作者: enterprise 時(shí)間: 2025-3-27 20:31
Using CRISPR/Cas9 to Edit a Thyroid Cancer Cell Line,he oncogenesis of thyroid cancer is related to genetic alterations in MAPK signaling that induce proliferation and modulate noncoding genes, such as microRNAs and long noncoding RNAs. In this context, CRISPR/Cas9 emerges as a potential tool to modify gene sequence and modulate gene expression in thy作者: 思鄉(xiāng)病 時(shí)間: 2025-3-27 22:29 作者: vector 時(shí)間: 2025-3-28 05:16 作者: 高興去去 時(shí)間: 2025-3-28 06:56 作者: 物質(zhì) 時(shí)間: 2025-3-28 13:42
CRISPR Libraries and Whole-Genome Screening to Identify Essential Factors for Viral Infections, activation, or editing. The advances in this technique make possible the development of CRISPR libraries which consist of a set of sgRNAs to cause perturbations in several genes in the same cell population. The use of libraries raised the CRISPR-Cas9 technique to a genomic scale and provides a powe作者: 易于交談 時(shí)間: 2025-3-28 16:48 作者: maladorit 時(shí)間: 2025-3-28 21:52 作者: Customary 時(shí)間: 2025-3-29 02:28
